At a glance
- Originator Nonindustrial source
- Class Antibacterials; Antituberculars
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycobacterium avium complex infections
Most Recent Events
- 14 Jan 2003 No development reported - Preclinical for Mycobacterium avium complex infections in USA (unspecified route)
- 25 Jan 2001 Preclinical development for Mycobacterium avium complex infections in USA (Unknown route)